Phosphatase and Tensin Homolog (PTEN)
PTEN (Phosphatase and Tensin Homolog) is a dual-specificity tumor suppressor protein encoded by the PTEN gene on chromosome 10q23.
PTEN (Phosphatase and Tensin Homolog) is a dual-specificity tumor suppressor protein encoded by the PTEN gene on chromosome 10q23. It functions primarily as a lipid phosphatase that dephosphorylates phosphatidylinositol (3,4,5)-trisphosphate (PIP3), thereby acting as the principal negative regulator of the Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB)/mTOR signaling pathway — one of the most frequently dysregulated axes in human cancer. By opposing the activity of PI3-kinase, PTEN limits Protein kinase B (PKB) activation and downstream pro-survival and proliferative signaling through the Mechanistic target of rapamycin (mTOR) (Mtor). Beyond its cytoplasmic phosphatase function, PTEN is also capable of nuclear translocation, where it participates in DNA damage response, chromosomal stability, and transcriptional regulation. Loss of PTEN function — through deletion, mutation, promoter silencing, or post-translational inhibition — is among the most common molecular alterations in human malignancy, occurring across many tumor types, and is frequently associated with poor prognosis, therapy resistance, and aggressive disease biology.
PTEN's tumor suppressive role extends beyond oncology. It is a critical regulator of neuronal survival, synaptic plasticity, and metabolic homeostasis, and its dysfunction has been implicated in neurodegenerative conditions, cognitive impairment, and metabolic syndromes. Because PTEN sits at the convergence of growth factor signaling, apoptosis, autophagy pathways, and immune regulation, it has emerged as a high-priority node in both basic and translational biomedical research.
Where the papers sit
19 papers from the last 6 months study Phosphatase and Tensin Homolog (PTEN) directly · updated from PubMed 13 Nov 2026
Study type 0 clinical trials · 1 observational · 15 preclinical · 3 unclassified
Themes one subject · 1 new direction
Those 19 are all about one subject.
-
PTEN Disease Biology
PTEN is examined as a regulator of AKT signaling, subcellular localization, tumor growth, vascular dysfunction, and neuronal injury. Cancer studies connect PTEN loss or pathway disruption with treatment sensitivity, radiotherapy combinations, immune resistance, and targeted drug delivery. miRNAs, exosomes, engineered cells, nanoparticles, and small-molecule inhibitors recur as ways to modify PTEN-linked disease processes. The work remains broad and exploratory, without a single dominant therapeutic direction.
PTEN nuclear translocation mediates anesthetic neurotoxicity
In aged female mice exposed repeatedly to sevoflurane, PTEN was studied as a mediator of hippocampal synaptic and cognitive injury rather than primarily as a tumor-suppressive signaling brake or a target for promoting neural regeneration. The study linked PTEN nuclear translocation to sevoflurane-associated synaptic and cognitive deficits and found that an estrogen receptor-α agonist protected against this toxicity through that PTEN-localization mechanism, extending PTEN into the control of anesthesia-induced neurodegeneration and cognitive dysfunction 42212628May.
Papers
The 19 papers from the last 6 months that study Phosphatase and Tensin Homolog (PTEN) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
PTEN Disease Biology (19)
- Evaluation of Murrayanine's Anticancer Potential in Breast Cancer: Integrative Computational, In Vitro, and Nanoparticle Delivery Approaches. The Journal of steroid biochemistry and molecular biology · 14 Oct 2026 PMID 42874789
- Phenylalanine 347 regulates the subcellular localization of PTEN. Biochemical and biophysical research communications · 3 Sept 2026 PMID 42691629
- Hsa-miR-498-5p serves as a diagnostic biomarker and regulates endothelial dysfunction via PTEN/AKT pathway in gestational hypertension. Biochemical and biophysical research communications · 7 Aug 2026 PMID 42566998
- Isolation of adipose-derived mesenchymal stromal cells expressing soluble forms of GAS1 and PTEN for experimental cell therapy for glioblastoma. Cytotherapy · 6 Aug 2026 PMID 42561643
- Development of a 3D collagen type I hydrogel scaffold for modeling hyperglycemia-induced spinal neuronal damage and therapeutic evaluation. Histochemistry and cell biology · 30 Jul 2026 PMID 42530656
- Hypoxia-induced mechanism of TNBC promoting tumour cell proliferation through exosomal miRNA. Mammalian genome : official journal of the International Mammalian Genome Society · 18 Jul 2026 PMID 42471478
- Synthesis, in vitro and in silico studies of transition metal complexes of chrysin with potent anticancer activity via GSK3β phosphorylation, modulation of p38 MAPK pathway and HDAC8 inhibition. Bioorganic chemistry · 17 Jul 2026 PMID 42468084
- Analysis of PTEN Antagonistic Peptides (PAPs) in Neuronal Growth and Traumatic Brain Injury (TBI). Biomacromolecules · 10 Jul 2026 PMID 42427105
- PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer. The Journal of clinical investigation · 7 Jul 2026 PMID 42412555
- CNOT9 affects hepatocellular carcinoma proliferation and cell cycle through the PTEN/AKT/p53 signaling pathway. Human cell · 1 Jul 2026 PMID 42384246
- Antitumor effect of the AP5Z1 small-molecule inhibitor PGG in hepatocellular carcinoma. Medical oncology (Northwood, London, England) · 25 Jun 2026 PMID 42347921
- Elevated serum miR-19a-3p serves as a diagnostic and prognostic biomarker for ischemic stroke and aggravates neuronal injury by targeting PTEN. Gene · 20 Jun 2026 PMID 42323115
- Exploiting androgen receptor agonism as a treatment strategy in estrogen receptor-positive metastatic breast cancer. NPJ breast cancer · 17 Jun 2026 PMID 42310300
- Single-ligand dual-targeting lipid nanoparticles for therapeutic mRNA delivery to glioblastoma across the blood-brain barrier. Journal of controlled release : official journal of the Controlled Release Society · 15 Jun 2026 PMID 42297114
- SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy. Science advances · 12 Jun 2026 PMID 42284420
- Targeting XIAP-coordinated PKC signaling resensitizes PD-1-refractory tumors for rechallenge. Proceedings of the National Academy of Sciences of the United States of America · 3 Jun 2026 PMID 42234523
- ERα Agonist Protects Aged Female Mice From Sevoflurane Neurotoxicity via PTEN Nuclear Translocation. CNS neuroscience & therapeutics · 29 May 2026 PMID 42212628
- Ethanolic extract of Otostegia fruticosa induces ROS-dependent apoptosis and reduces migration of MDA-MB-231 cells in vitro. PloS one · 26 May 2026 PMID 42189838
- Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury. Journal of molecular histology · 21 May 2026 PMID 42165939
By study type
Observational studies and case reports (1)
- Elevated serum miR-19a-3p serves as a diagnostic and prognostic biomarker for ischemic stroke and aggravates neuronal injury by targeting PTEN. Gene · 20 Jun 2026 PMID 42323115
Preclinical: animal, cell and lab studies (15)
- Phenylalanine 347 regulates the subcellular localization of PTEN. Biochemical and biophysical research communications · 3 Sept 2026 PMID 42691629
- Hsa-miR-498-5p serves as a diagnostic biomarker and regulates endothelial dysfunction via PTEN/AKT pathway in gestational hypertension. Biochemical and biophysical research communications · 7 Aug 2026 PMID 42566998
- Isolation of adipose-derived mesenchymal stromal cells expressing soluble forms of GAS1 and PTEN for experimental cell therapy for glioblastoma. Cytotherapy · 6 Aug 2026 PMID 42561643
- Development of a 3D collagen type I hydrogel scaffold for modeling hyperglycemia-induced spinal neuronal damage and therapeutic evaluation. Histochemistry and cell biology · 30 Jul 2026 PMID 42530656
- Hypoxia-induced mechanism of TNBC promoting tumour cell proliferation through exosomal miRNA. Mammalian genome : official journal of the International Mammalian Genome Society · 18 Jul 2026 PMID 42471478
- Synthesis, in vitro and in silico studies of transition metal complexes of chrysin with potent anticancer activity via GSK3β phosphorylation, modulation of p38 MAPK pathway and HDAC8 inhibition. Bioorganic chemistry · 17 Jul 2026 PMID 42468084
- Analysis of PTEN Antagonistic Peptides (PAPs) in Neuronal Growth and Traumatic Brain Injury (TBI). Biomacromolecules · 10 Jul 2026 PMID 42427105
- PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer. The Journal of clinical investigation · 7 Jul 2026 PMID 42412555
- CNOT9 affects hepatocellular carcinoma proliferation and cell cycle through the PTEN/AKT/p53 signaling pathway. Human cell · 1 Jul 2026 PMID 42384246
- Antitumor effect of the AP5Z1 small-molecule inhibitor PGG in hepatocellular carcinoma. Medical oncology (Northwood, London, England) · 25 Jun 2026 PMID 42347921
- SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy. Science advances · 12 Jun 2026 PMID 42284420
- Targeting XIAP-coordinated PKC signaling resensitizes PD-1-refractory tumors for rechallenge. Proceedings of the National Academy of Sciences of the United States of America · 3 Jun 2026 PMID 42234523
- ERα Agonist Protects Aged Female Mice From Sevoflurane Neurotoxicity via PTEN Nuclear Translocation. CNS neuroscience & therapeutics · 29 May 2026 PMID 42212628
- Ethanolic extract of Otostegia fruticosa induces ROS-dependent apoptosis and reduces migration of MDA-MB-231 cells in vitro. PloS one · 26 May 2026 PMID 42189838
- Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury. Journal of molecular histology · 21 May 2026 PMID 42165939
Unclassified: not yet indexed with MeSH (3)
- Evaluation of Murrayanine's Anticancer Potential in Breast Cancer: Integrative Computational, In Vitro, and Nanoparticle Delivery Approaches. The Journal of steroid biochemistry and molecular biology · 14 Oct 2026 PMID 42874789
- Exploiting androgen receptor agonism as a treatment strategy in estrogen receptor-positive metastatic breast cancer. NPJ breast cancer · 17 Jun 2026 PMID 42310300
- Single-ligand dual-targeting lipid nanoparticles for therapeutic mRNA delivery to glioblastoma across the blood-brain barrier. Journal of controlled release : official journal of the Controlled Release Society · 15 Jun 2026 PMID 42297114
Written from 19 PubMed abstracts, each one listed by PMID above. Published: 2026-06-16. Last written: 2026-08-26 by GPT. Drafted by language models from published abstracts; not medical advice.